A glow of HLA typing in organ transplantation

Clinical and Translational Science

Volumn 2, Issue 6, 2013, Pages

  Mahdil, Batool mutar ^a  

^a UNIVERSITY OF BAGHDAD   (Iraq)

Author keywords

Major histocompatibility; Rejection; Transplantation

Indexed keywords

HLA ANTIBODY; HLA B ANTIGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIBODY DETECTION; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; HLA MATCHING; HLA TYPING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MIXED LYMPHOCYTE CULTURE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REFERENCE STRAND CONFORMATION ANALYSIS; REVIEW; SEQUENCE BASED TYPING; SEQUENCE SPECIFIC OLIGONUCLEOTIDE PROBE HYBRIDIZATION; SEQUENCE SPECIFIC PRIMING AMPLIFICATION; TISSUE TYPING;

EID: 84965144511     PISSN: 17528054     EISSN: 17528062     Source Type: Journal    
DOI: 10.1186/2001-1326-2-6     Document Type: Review

References (44)

1. Erlich HA, Opelz G, Hansen J: HLA DNA typing and transplantation. Immunity 2001, 14: 347-356.
2. Saiki RK, Bugawan TL, Horn GT, Mullis KB, Erlich HA: Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes. Nature 1986, 324: 163-166.
3. Anasetti C, Amos D, Beatty PG, Applebaum FR, Bensinger W, Buckner CD, Clift R, Doney K, Martin PJ, Mickelson E, Nisperos B, O'Quigley J, Ramberg R, SandersJ E, Stewart P, Storb R, Sullivan KM, Witherspoon RP, Thomas ED, Hansen JA: Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med 1989, 320: 197-204.
4. Sheldon S, Poulton K: HLA typing and its influence on organ transplantation. Methods Mol Biol 2006, 333: 157-174.
5. Le Bouteiller P, Lenfant F: Antigen-presenting function (s) of the non-classical HLA-E,-F and-G class I molecules: the beginning of a story. Res Immunol 1996, 147: 301-313.
6. Klein JAN, Sato A: The HLA system: first of two parts. N Engl J Med 2000, 343 (10): 702-709.
7. Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Geraghty DE, Hansen JA, Hurley CK, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI, Trowsdale J: Nomenclature for factors of the HLA System, 2004. Tissue Antigens 2005, 65: 301-369.
8. Marsh SGE, Albert ED, Bodmer WF, et al: Nomenclature for factors of the HLA system, 2010. Tissue Antigens 2010, 75: 291-455.
9. Parham P, Ohta T: Population Biology of Antigen Presentation by MHC class I Molecules. Science 1996, 272: 67-74.
10. Robinson J, Waller MJ, Fail SC, McWilliam H, Lopez R, Parham P, Marsh SGE: IMGT/HLA Database. Neucleic Acid Res 2009, 37: 1013-1017.
11. Rodey GE, Fuller TC: Public epitopes and the antigenic structure of the HLA molecules. Crit Rev Immunol 1987, 7: 229-267.
12. Carcia MA, Yebra BG, Flores ALL, Guerra EG: The major histocompatibility complex in transplantation. J Transplan 2012, 20: 842141.
13. Pratt JR, Basheer SA, Sacks SH: Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med 2002, 8: 582-587.
14. Guaní -Guerra E, Santos-Mendoza T, Lugo-Reyes SO, Terán LM: Antimicrobial peptides: general overview and clinical implications in human health and disease. Clin Immunol 2010, 135: 1-11.
15. Opelz G, Mytilineos J, Scherer S, et al: Survival of DNA HLA-DR typed and matched cadaver kidney transplants. Lancet 1991, 338: 461-463.
16. Takemoto SK, Terasaki PI, Gjertson DW, Cecka JM: Twelve years' experience with national sharing of HLA-matched cadaveric kidneys for transplantation. N Engl J Med 2000, 343: 1078-1084.
17. Jung HL: Shedding a new light on the HLA matching. Korean J Hematol 2011, 46: 1-2.
18. De Santis D, Dinauer D, Duke J, Erlich HA, Holcomb CL, Lind C, Mackiewicz K, Monos D, Moudgil A, Norman P, Parham P, Sasson A, Allcock RJ: 16 (th) IHIW: review of HLA typing by NGS. Int J Immunogenet 2013, 40: 72-76.
19. Schiller JJ, Hopp KA, Pietz BC, Bick DP, Lau EC, Ellis TMA: Simplified method for screening siblings for HLA identity using short tandem repeat (STR) polymorphisms. Hum Immunol 2013, 3: 00689.
20. Koclega A, Markiewicz M, Siekiera U, Dobrowolska A, Sylwia M, Dzierzak-Mietla M, Zielinska P, Kruszelnicka MS, Lange A, Kyrcz-Krzemien S: The presence of Anti-HLA antibodies before and after Allogeneic hematopoietic stem cells transplantation from HLA-mismatched unrelated donors. Bone Marrow Res 2012, 24: 539825.
21. Warren RP, Storb R, Weiden PL, Su PJ, Thomas ED: Lymphocyte-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity in patients with aplastic anemia: distinguishing transfusion-induced sensitization from possible immune-mediated aplastic anemia. Transplant Proc 1981, 13: 245-247.
22. Bodmer JG, Marsh SG, Albert ED, Bodmer WF, Dupont B, Erlich HA, Mach B, Mayr WR, et al: Nomenclature for factors of the HLA system. Hum Immunol 1991, 34: 4-18. 1992.
23. Lim SH, Patton WN, Jobson S, Gentle TA, Baynham MID, Franklin IM, Boughton BJ: Mixed lymphocyte reactions do not predict severity of graft versus host disease (GVHD) in HLA-DR compatible, sibling bone marrow transplants. J Clin Pathol 1988, 41: 1155-1157.
24. Dunckley H: HLA typing by SSO and SSP methods. Methods Mol Biol 2012, 882: 9-25.
25. Adib M, Yaran M, Rezaie A, Solgi GHLA-DR: Typing by polymerase chain reaction with sequence-specific primers compared to serological typing. J Res Med Sci 2004, 6: 255-259.
26. Smith LK: HLA typing by direct DNA sequencing. Methods Mol Biol 2012, 882: 67-86.
27. Qureshi BH: Consensus and controversies on HLA matching and crossmatching in transplantation. Saudi J Kidney Dis Transpl 1997, 8: 138-144.
28. Tait BD, Süsal C, Gebel HM, Nickerson PW, Zachary AA, Claas FH, Reed EF, Bray RA, Campbell P, Chapman JR, Coates PT, Colvin RB, Cozzi E, Doxiadis II, Fuggle SV, Gill J, Glotz D, Lachmann N, Mohanakumar T, Suciu-Foca N, Sumitran-Holgersson S, Tanabe K, Taylor CJ, Tyan DB, Webster A, Zeevi A, Opelz G: Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation 2013, 15: 19-47.
29. Bray RA, Tarsitani C, Gebel HM, Lee JH: Clinical cytometry and progress in HLA antibody detection. Methods Cell Biol 2011, 103: 285-310.
30. Gloor J, Stegall MD: Sensitized renal transplant recipients: current protocols and future directions. Nat Rev Nephrol 2010, 6: 297-306.
31. Minucci PB, Grimaldi V, Casamassimi A, et al: Methodologies for anti-HLA antibody screening in patients awaiting kidney transplant: a comparative study. Exp Clin Transplant 2011, 9: 381-386.
32. Süsal C, Opelz G: Impact of HLA matching and HLA antibodies in organ transplantation: a collaborative transplant study view. Methods Mol Biol 2012, 882: 267-277.
33. Opelz G, Döhler B: Multicenter analysis of kidney preservation. Transplantation 2007, 83: 247-253.
34. Opelz G, Döhler B: Impact of HLA mismatching on incidence of posttransplant non-Hodgkin lymphoma after kidney transplantation. Transplantation 2010, 89: 567-572.
35. Nikkel LE, et al: Risk of fractures after renal transplantation in the United States. Transplantation 2009, 87: 1846-1851.
36. Meier-Kriesche HU, et al: A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients. Transplantation 2009, 88: 23-29.
37. Süsal C, Döhler B, Opelz G: Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a collaborative transplant study report. Hum Immunol 2009, 70: 569-573.
38. El-Awar N, et al: Almost all patients who are waiting for a regraft of a kidney transplanthave anti-HLA antibodies. Transplant Proc 2002, 34: 2531-2532.
39. Opelz G, Collaborative Transplant Study: Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies. Lancet 2005, 365: 1570-1576.
40. Zou Y, et al: Detection of anti-MICA antibodies in patients awaiting kidney transplantation, during the post-transplant course, and in eluates from rejected kidney allografts byLuminex flow cytometry. Hum Immunol 2006, 67: 230-237.
41. Reinsmoen NL, et al: Anti-angiotensin type 1 receptor antibodies associated with antibody mediated rejection in donor HLA antibody negative patients. Transplantation 2010, 90: 1473-1477.
42. Morath C, et al: An integrative approach for the transplantation of high-risk sensitized patients. Transplantation 2010, 90: 645-653.
43. Heinold A, Opelz G, Döhler B, Unterrainer C, Scherer S, Ruhenstroth A, Hien TT: Deleterious impact of HLA-DRB1 allele mismatch in sensitized recipients of kidney retransplants. Transplantation 2013, 15: 137-141.
44. Wang H, He Y, Zhai WJ, Wang M, Zhou Z, Zhao YX, Feng SZ, Han MZ: The impact of recipient HLA-Cw and donor killer immunoglobulin-like receptor genotyping on the outcome of patients receiving HLA-matched sibling donor hematopoietic stem cell transplantation for myeloid malignancies. Swiss Med Wkly 2013, 8: 143.0.